Firm & fund profile / Sourced portfolio
Eli Lilly and Company
Tracked participation in 1 Atlas company, with 0 explicitly attributed leads.
1portfolio companies
1round participations
0lead positions
Jun 2026latest activity
Capital activity
Portfolio
CompanyLatest valuationFirst → latestRoundsRoleLatest round
A
Abridge—Jun 2026 → Jun 20261 roundParticipantStrategic / corporate minority investment (undisclosed amount)